Jennifer Buell insider trades

Open-market stock purchases and sales by Jennifer Buell, Chief Executive Officer at MiNK Therapeutics, Inc, from SEC Form 4 filings since Sep 3, 2017.

Recent trades

DateStockTradeValue
Oct 12, 2026INKT MiNK Therapeutics, IncSold$73.3K
Oct 11, 2026INKT MiNK Therapeutics, IncBought (not open market)—
Oct 11, 2026INKT MiNK Therapeutics, IncBought (not open market)—
Aug 5, 2026AGEN Agenus IncBought (not open market)—
Apr 24, 2026AGEN Agenus IncBought (not open market)—
Apr 24, 2026AGEN Agenus IncBought (not open market)—
Jan 2, 2026INKT MiNK Therapeutics, IncBought (not open market)$350K
Jan 2, 2026INKT MiNK Therapeutics, IncBought (not open market)—
Jan 2, 2026INKT MiNK Therapeutics, IncSold (not open market)$111K

Companies traded

  • INKT MiNK Therapeutics, Inc: 1 sale, last Oct 12, 2026
  • AGEN Agenus Inc: 1 sale, last Aug 5, 2026
  • PTIX Protagenic Therapeutics, Inc.\new: other filings, last Mar 25, 2024

Get free alerts when Jennifer Buell files a new trade →